Article
Polymorphisms in the CD6-ALCAM axis may modulate psoriasis risk and outcomes.
Human immunology - 1 May 2024
Wagner Marta, Sobczyński Maciej, Wiśniewski Andrzej, Matusiak Łukasz, Kuśnierczyk Piotr, Jasek Monika
Abstract excerpt
The fact that CD6, along with its ligand - ALCAM, plays a role in regulating T cell activation makes the genes encoding these molecules promising candidates for research in T cell-mediated diseases such as psoriasis vulgaris (PsV). Our study aimed to determine whether CD6 (rs17824933C>G, rs11230563C>T and rs12360861G>A) and ALCAM (rs6437585C>T, rs11559013G>A) polymorphisms may affect psoriasis susceptibility and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
